Net Profit Margins
Kiniksa Pharmaceuticals Ltd’s revenue jumped +Inf% since last year same period to $18.75Mn in the Q4 2021. On a quarterly growth basis, Kiniksa Pharmaceuticals Ltd has generated 54.98% jump in its revenue since last 3-months.
Kiniksa Pharmaceuticals Ltd’s net profit jumped 32.29% since last year same period to $-36.33Mn in the Q4 2021. On a quarterly growth basis, Kiniksa Pharmaceuticals Ltd has generated -18.95% fall in its net profits since last 3-months.
Kiniksa Pharmaceuticals Ltd’s net profit margin jumped NaN% since last year same period to -193.83% in the Q4 2021. On a quarterly growth basis, Kiniksa Pharmaceuticals Ltd has generated 23.25% jump in its net profit margins since last 3-months.
EPS Estimate Current Quarter
EPS Estimate Current Year
Kiniksa Pharmaceuticals Ltd’s earning per share (EPS) estimates for the current quarter stand at -0.22 - a -128.21% fall from last quarter’s estimates.
Kiniksa Pharmaceuticals Ltd’s earning per share (EPS) estimates for the current year stand at -0.22.
Return on Assets (ROA)
Return on Equity (ROE)
Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Kiniksa Pharmaceuticals Ltd’s return on assets (ROA) stands at 0.02.
The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Kiniksa Pharmaceuticals Ltd’s return on equity (ROE) stands at 0.63.
|Earnings Date||Estimated EPS||Reported EPS||Surprise %|
Kiniksa Pharmaceuticals Ltd
Clarendon House, Hamilton, Bermuda, HM 11
Trading and brokerage services provided by
Banking and Remittance services provided by
Technology services provided by : Finzoomers Services Private Limited
Disclaimer: These services are not for exchange traded products.The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Finzoomers Services Private Limited acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*